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https://doi.org/10.1016/j.stemcr.2020.04.007SUMMARYMultiple protocols have been published for generation of iMGLs from hESCs/iPSCs. To date, there are no guides to assist researchers to
determine the most appropriate methodology for microglial studies. To establish a framework to facilitate future microglial studies, we
first performed a comparative transcriptional analysis between iMGLs derived using three published datasets, which allowed us to estab-
lish the baseline protocol that is most representative of bona fide human microglia. Secondly, using CRISPR to tag the classic microglial
marker CX3CR1 with nanoluciferase and tdTomato, we generated and functionally validated a reporter ESC line. Finally, using this cell
line, we demonstrated that co-culture of iMGL precursors with human glia and neurons enhanced transcriptional resemblance of iMGLs
to ex vivomicroglia. Together, our comprehensivemolecular analysis and reporter cell line are a useful resource for neurobiologists seeking
to use iMGLs for disease modeling and drug screening studies.INTRODUCTION
Microglia, the resident macrophages of the central nervous
system, are essential for brain development and function
(Paolicelli et al., 2011; Thion et al., 2018), and have been
genetically, epigenetically (Gjoneska et al., 2015), and tran-
scriptionally (Zhang et al., 2013) shown to be directly
involved in neurodegenerative diseases, including Alz-
heimer’s disease and multiple sclerosis (Skene and Grant,
2016).
iPSC/hESC-derived cells are a useful research platform,
potentially more representative of human development
and systems compared with cell lines or animal models.
Recently, multiple protocols described differentiation of
human embryonic or human induced pluripotent stem
cells (hESCs or iPSCs, respectively) toward microglia-
like cells (iMGLs) (Abud et al., 2017; Brownjohn et al.,
2018; Douvaras et al., 2017; Garcia-Reitboeck et al.,
2018; Haenseler et al., 2017; Konttinen et al., 2019; Muf-
fat et al., 2016; Ormel et al., 2018; Pandya et al., 2017;
Takata et al., 2017). The differences between these proto-
cols inherently result in transcriptomic and functional
variation between the iMGLs generated, thus it is critical
to understand which most closely resemble in vivo
microglia.1018 Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020 j ª 2020 The A
This is an open access article under the CC BY-NC-ND license (http://creativPrimary microglia rapidly downregulate key signature
genes upon in vitro culture (Gosselin et al., 2017), indi-
cating that growth factors currently utilized for in vitro
culture are insufficient for establishment or maintenance
of microglial identity. To study microglia and examine
their interactions with other cells, it is useful to track per-
manent reporter expression targeted onto a key micro-
glial gene.
In this brief report, we performed a molecular compari-
son of three existing iMGL differentiation strategies to
identify the baseline protocol most similar to ex vivo mi-
croglia. Next, we used a dual CRISPR/Cas9-nickase system
to selectively target one allele of the microglial marker
CX3CR1 in the H9 hESC line, tagging the gene with a
dual fluorescent/enzymatic construct, while ensuring
physiological expression of CX3CR1 protein. We func-
tionally validated iMGLs derived from this reporter cell
line, demonstrating expression of key microglial markers,
functional cytokine responses, and internalization of syn-
aptosome fragments. Finally, we demonstrated that co-
culture of iMGLs with human glia and neurons improves
the transcriptional identity of iMGLs. Our reporter line
and integrative transcriptional analysis can be utilized
by researchers worldwide to further improve iMGL molec-
ular signatures, with the ultimate aim of accuratelyuthors.
ecommons.org/licenses/by-nc-nd/4.0/).
recapitulating in vivo microglia for disease modeling and
drug screening applications.RESULTS AND DISCUSSION
Molecular Comparison of Existing Microglia
Differentiation Protocols
Since the first description of a directed differentiation proto-
col yielding IBA1+CD11b+CD45+ cells from a hiPSC or hESC
lineage in 2016 (Muffat et al., 2016), to date at least ten dif-
ferentiation protocols have been described to generate iPS-
derived microglia-like cells (iMGLs, Table 1) (Abud et al.,
2017; Brownjohn et al., 2018; Douvaras et al., 2017; Gar-
cia-Reitboeck et al., 2018; Haenseler et al., 2017; Muffat
et al., 2016; Ormel et al., 2018; Pandya et al., 2017; Takata
et al., 2017; Konttinen et al., 2019). However, the transcrip-
tomes generated by these protocols have only been
compared with primary microglia cultured in vitro, and
bona fide ex vivo microglia rapidly change identity upon
in vitro culture resulting in 6,000 genes deregulated over
2-fold (Gosselin et al., 2017). Thus, there is a need formicro-
glia researchers to determine which of these protocols to
adopt or adapt for their own studies. The protocols differ pri-
marily by the method used to generate microglial progeni-
tors, with some methods relying on embryoid body forma-
tion to generate mesoderm (Brownjohn et al., 2018;
Garcia-Reitboeck et al., 2018; Haenseler et al., 2017; Muffat
et al., 2016; Takata et al., 2017), whereas others follow a
2D induction of mesoderm myeloid differentiation (Abud
et al., 2017; Douvaras et al., 2017; Pandya et al., 2017; Kont-
tinen et al., 2019), and some protocols purify intermediates
by fluorescence-activated cell sorting (FACS) (Abud et al.,
2017; Douvaras et al., 2017) or magnetic-activated cell sort-
ing (Pandya et al., 2017). A recent study also detected native
iMGL development within cerebral organoids (Ormel et al.,
2018), previously found to be devoid of myeloid cells. The
difficulty of comparing protocols is further confounded by
the different, although partially overlapping, functional
validation experiments used. We, therefore, utilized two
recent landmark publications that for the first time tran-
scriptionally profiled ex vivo FACS-isolated microglia from
fresh postmortem or surgery-resected human brain (Galatro
et al., 2017; Gosselin et al., 2017), to compare with the bona
fide microglial transcriptional signature. In our analysis, we
included all studies containing iMGLs that were profiled by
RNA sequencing (RNA-seq), and that contained at least one
common group with any other dataset, for the purpose of
cross-study normalization (Abud et al., 2017; Douvaras
et al., 2017; Muffat et al., 2016) (Table 1). Thus, we excluded
datasets with only microarray data (Haenseler et al., 2017;
Pandya et al., 2017), no RNA-seq for hiMGLs (Garcia-Reit-
boeck et al., 2018; Takata et al., 2017), and datasets contain-ing no additional common sequencing groupother than the
iMGLs generated in that study (Brownjohn et al., 2018;
Konttinen et al., 2019). Our results revealed that ex vivomi-
croglia clustered close together irrespective of the study or
fresh postmortem compared with surgery-resected origin
of the cells, providing confidence in the method used for
normalization (Figure 1A). Similarly, the brain lysate groups
sequenced in both studies clustered together. Our results
suggest that the first MDS dimension was dominated by
the transition from non-myeloid to myeloid cells, and that
the second dimension represented the differences in envi-
ronment ex vivo to in vivo. The third dimension separated
cells present in the brain from peripheral cells, as ex vivo
monocytes and dendritic cells separated from ex vivomicro-
glia primarily in this dimension (Figure 1B). These results
show that there is a component of environment, and partic-
ularly of brain environment, in addition to themyeloid line-
age that needs to be faithfully recapitulated for amolecularly
representative model of microglia. Of the iMGL protocols
compared in this study, the protocol of Abud et al. (2017)
most closely resembled ex vivo microglia transcriptionally,
and clustered with bona fide microglia after at least 24 h
in vitro culture (Figures 1A and1B). The additional iMGLpro-
tocols examined here clustered more closely with in-vitro-
cultured fetal microglia (pFMGLs), and thus may require
further maturation. Furthermore, the higher internal vari-
ability of differentiations in (Muffat et al., 2016) compared
with other protocols may suggest that either embryoid
body formation or multiple sequential collections of pro-
genitors over several weeks may inherently generate more
variability than multi-step synchronized directed differenti-
ation or FACS isolation of pure target populations.
We first examined whether we could generate iMGLs that
molecularly and functionally resembled iMGLs in our
hands, and thus whether the protocol of (Abud et al.,
2017) was robust to be adopted in multiple different labs.
As the astrocyte-derived factors necessary for microglial sur-
vival and ramification in vitro were interleukin-34 (IL-34),
colony-stimulating factor 1 (CSF1), transforming growth
factor b1 (TGF-b1), and cholesterol (Bohlen et al., 2017),
and the iMGL maturation media described in Abud et al.
(2017) contained all but cholesterol, we also added choles-
terol to the differentiation protocol. We showed that, in
our hands in two independent labs, the differentiation
stages morphologically followed those initially described
(Figure 1C) and was consistent for iMGLs generated from
eight iPSC lines tested comprising three control lines, three
AD patient lines, and two CRISPR-corrected lines (Oksanen
et al., 2017). We showed that D12 HPCs lost TRA-1-60 and
gained CD43 expression and that, at D38, iMGLs uniformly
expressed CD45 and CD11b (Figure S1A). iMGLs also ex-
pressed IBA1 as shown by immunofluorescence (IF) (Fig-
ure S1B). Moreover, iMGLs phagocytosed pHrodo Red-Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020 1019
Table 1. Comparison of the Protocols and Validation Strategies of Currently Available Protocols for the Generation of Human iMGLs
Study
Protocol Validation
Co-culture? GEOMesoderm FACS/MACS Maturation
Yield, 3106
iMGLs per
106 iPSCs Molecular
Molecular
Comparisona Functional
Muffat et al.,
2016, Nature
Medicine
EB No M-CSF, IL-34 0.5–4 RNA-seq,
FACS, IF
pFMGL phagocytosis: beads; cytokine secretion;
motility: scratch test, migration to injury
hiPS-derived
neurons + glia:
2D, 3D
GEO: GSE85839
Pandya et al.,
2017, Nature
Neuroscience
2D MACS d15
CD34+/CD43+
human astrocyte
co-culture + GM-CSF,
M-CSF, IL-3
0.8–3 microarray,
FACS, IF
pFMGL phagocytosis: pHrodo E. coli; ROS production human astrocytesb GEO: GSE78116
Abud et al.,
2017, Neuron
2D FACS d10
CD43+
M-CSF, IL-34, TGF-b1,
insulin; D35-38 +
CD200, CX3CL1
30–40 RNA-seq,
FACS, IF
pFMGL, pAMGL phagocytosis: synaptosomes, Ab tau
oligomers; cytokine secretion; migration; Ca
response to ADP
rat hippocampal
neurons, hiPS-
derived organoids,
in vivo transplant
GEO: GSE89189
Douvaras et al.,
2017, Stem Cell
Reports
2D FACS d25
CD14+
CX3CR1+
IL-34, GM-CSF 2.24 ± 0.42 RNA-seq,
FACS, IF
pAMGL, pFMGL,
pAMGL +
Douvaras
media
phagocytosis: microspheres; Ca response to
ADP
no GEO: GSE97744
Takata et al.,
2017, Immunity
2D No co-culture with iPSC-
derived neurons
10–20 FACS, CyTOF iMacs phagocytosis: Ab, latex beads hiPS-derived
neurons
Haenseler et al,
2017, Stem Cell
Reports
EB No IL-34 10–43 microarray,
FACS, IF
exMGL (fetal);
exMGL (qPCR
only, n = 1)
motility; response to LPS: clustering;
morphology; cytokine secretion; neurons +
iMGLs: electrophysiology, neuron
morphology, synapse IF
hiPS-derived
cortical neurons
GEO: GSE89795
Brownjohn et al.,
2018, Stem Cell
Reports
EB No GM-CSF, IL-34 23–52 RNA-seq, IF none phagocytosis: pHrodo E. coli; cytokine
secretion
hiPS-derived
organoid
GEO: GSE110952
Garcia-Reitboeck
et al., 2018, Cell
Reports
EB No M-CSF NA qPCR, FACS,
IF
PBMC, pMac phagocytosis: pHrodo E. coli, pHrodo
zymosan, apoptotic neurons; motility:
scratch test, transwell assay; cytokine
secretion
no
Ormel et al.,
2018, Nature
Communications
organoid No within organoid N/A RNA-seq,
FACS, IF
ex vivo CD45+,
CD11b+
phagocytosis: iC3b; cytokine secretion;
PSD95 internalization (confocal)
organoid GEO: GSE102335
Konttinen et al.,
2019, Stem
Cell Reports
2D No M-CSF, IL-34 20 RNA-seq,
FACS, IF
none Ca response to ADP/ATP; scratch test;
phagocytosis: pHrodo, FITC, Ab; cytokine
secretion; mitochondrial metabolism
iPS-derived
neurons in 3D,
organoids
GEO: GSE135707
EB, embryoid body; CyTOF, cytometry by time of flight; FITC, fluorescein isothiocyanate; GM-CSF, granulocyte-macrophage colony-stimulating factor; IF, immunofluorescence; M-CSF, macrophage col-
ony-stimulating factor; MACS, magnetic-activated cell sorting; PBMC, peripheral blood mononuclear cell; ROS, reactive oxygen species; TGF, transforming growth factor.
aSequenced in that study.
bSource of astrocytes is not specified.
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Figure 1. Comparison of Existing Differentiation Protocols and Differentiation of iPSCs to iMGLs
(A and B) Multidimensional scaling (MDS) analysis of the integrated datasets, presented as MDS dimension 1 versus 2 (A) and 2 versus 3 (B)
showing separation of ex vivomicroglia (exMGL), fetal or adult primary microglia—pFMGL or pAMGL cultured without, or in the presence of
serum; +serum), iMGLs generated using various published protocols (_abud, _douvaras, _muffat), and ex vivo brain lysate (exBrain). For
comparison and normalization, we also included various in-vitro-generated stem cell transcriptomes (iPSCs, iHPCs, and iNPCs) and primary
peripheral blood mononuclear cells (pPBMCs), or other ex vivo myeloid cells (ex vivo monocytes, exM, and ex vivo dendritic cells, exDC).
(C) Bright-field micrographs showing colony and cell morphology at various points throughout the differentiation process, representative
of >30 independent differentiations using eight independent iPSC lines. Scale bars, 100 mm.
(legend continued on next page)
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labeled E. coli, with enhanced phagocytosis (Figure 1D) and
increased cytokine responses (Figure S1C) in response to
lipopolysaccharide (LPS) stimulation. These data suggest
that the differentiation protocol described by Abud et al.
(2017) was readily adaptable in multiple labs. Thus, using
this protocol as a baseline, we designed an approach to
generate a tool for the microglial community that would
facilitate established and emerging microglial researchers
alike to examine microglial identity and functions in vitro
and in vivo, in the context of physiology and disease
(Figure 1E).
CRISPR Generation and Validation of CX3CR1-
tdTomato H9 ESCs for Tracking Microglial
Differentiation
We reasoned that amicroglial reporter linewould be a useful
tool for the derivation of microglia and to allow efficient
identification and live cell tracking of microglial cells
in vitro and in vivo allowing rapid cell sorting without the
need for additional labeling. Thus, we used a CRISPR/
Cas9-derivedmethod to facilitate insertion of a dual fluores-
cent (tdTomato) and enzymatic (nanoLuc) reporter into H9
cells. We chose to use a CRISPR system described previously
(Mali et al., 2013; Ran et al., 2013), which utilizes dual Cas9-
nickase constructs, to reduce the incidence of off-target dou-
ble-strand breaks. Our donor vector contained two selection
cassettes, a diphtheria toxin A (DTA) cassette, a neomycin/
kanamycin resistance cassette, as well as two homology
arms for the CX3CR1 gene (Figure 2A; Experimental Proced-
ures). The donor vector enabled replacement of the stop
codon of the CX3CR1 open reading frame with an IRES-
tdTomato-T2A-Nanoluc-polyA-FRT-Neo-FRT construct. The
DTA cassette was designed so that correct insertion of the
donor vector into the host CX3CR1 locus resulted in exci-
sion of the DTA cassette. Clones were screened by PCR and
Southern blot to confirm targeting (Figures S1D and S1E),
confirmed to be free of chromosomal aberrations via karyo-
typing (Figure S1F), and confirmed to be pluripotent by tera-
toma assay (Figure S1G).
To validate that the nanoluciferase reporter was func-
tional and not silenced in iMGLs, we measured nanoluci-
ferase enzymatic activity in media harvested from H9 and
H9-CX3CR1-tdTomato iMGLs at different time points
throughout differentiation and showed increased lumines-
cence in H9-CX3CR1-tdTomato but not H9 cells from D12
(Figure 2B). To verify that the fluorescent reporter construct
was also functional, we generated iMGLs from the targeted(D) iMGLs phagocytose pHrodo E. coli particles basally and after LPS s
bars, 50 mm.
(E) Schematic of microglia differentiation protocol (adapted from Abud
study.
See also Figure S1.
1022 Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020H9 reporter cell line and examined the expression of the
fluorescent reporter compared with endogenous CX3CR1
by FACS. tdTomato expression correlated with expression
of CX3CR1 by FACS, and insertion of the reporter did not
interfere with expression of CD11b, CD45, or TREM2,
and iMGLs remained negative for the macrophage-specific
marker CCR2 (Figure 2C). We confirmed that H9-CX3CR1-
tdTomato iMGLs expressed P2RY12 and TREM2, as well as
the tdTomato reporter and CX3CR1 (Figures 2D, S1H, and
S1I). Together, our data suggest that both the fluorescent
and enzymatic reporters are functional in this cell line
and can be used to track iMGL differentiation via
CX3CR1 expression in cells and media using FACS, IF, or
luminescence approaches.
We next used this line to track kinetics of surface marker
expression changes during differentiation and to determine
the order of changes as iPSCs differentiate to iMGL. Thus,
we followed the loss of the pluripotency marker TRA-1-60,
which was lost in over 50% of cells from D4, and was
entirely absent from non-adherent iHPCs by D12 of differ-
entiation (Figures 2E and S2A). Loss of TRA-1-60 preceded
acquisition of primitive lymphoid/myeloid marker CD43,
which was present on 98% of non-adherent cells (iHPCs)
by D12. Approximately 15% of iHPCs also co-expressed
CD11b and CD45, and most of these cells (84.6%) were
also positive for the CX3CR1 tdTomato reporter (Figures
2E and S2A) by FACS. A proportion of CD43+ cells at D12
(30.9%) also upregulated CD235a independently of
CX3CR1 expression (Figure S2A). Of the microglial markers
CD11b, CD45, CX3CR1, and TREM2, 73%–99% of cells ex-
pressed CD11b, CD45, and CX3CR1 by D18, and over 90%
of cells expressed these markers by D24 (Figures 2F, S2B–D).
Of the surface markers we examined, TREM2 was the last to
be upregulated and most variably expressed between indi-
vidual clones and individual differentiations using the
same clone (Figure S2D). The pattern of TREM2 expression
during iMGL maturation tended to either show a progres-
sive increase in TREM2 staining from D18 to D32, or show
highest TREM2 expression at D18, before a transient
decrease in TREM2 expression, followed by increase at
D32 (Figure S2D). At most, 90% of iMGLs were TREM2+
by D32, although for some differentiations this number
was as small as 12%. Together, our data show the kinetics
of surface marker expression during iMGL differentiation
and demonstrate how the reporter cell line generated in
this study can be used to track differentiation kinetics in
response to different stimuli or for drug screening.timulation, representative of n = 3 independent experiments. Scale
et al., 2017) and microglia reporter validation strategy used in this
AB
D
E F
C
Figure 2. Generation of a Dual Microglia Reporter ESC Line and Kinetics of Differentiation to iMGLs
(A) Schematic illustrating the CRISPR vector used for insertion of the tdTomato and nanoluciferase gene into the genome. Long homology
arm (LHA) and short homology arm (SHA) for CX3CR1 were designed, using an IRES linker for tdTomato expression. cDNAs encoding
tdTomato and nanoluciferase were linked with a T2A fragment, allowing translation of both proteins. A neomycin/kanamycin resistance
cassette under the control of a PGK promoter was included for positive selection of correctly targeted clones. A DTA coding cassette was
also included for negative selection of cells that do not correctly integrate the donor vector.
(B) Detection of luciferase secretion at various differentiation stages in H9 CX3CR1-tdTomato or H9 iMGLs. Error bars are SEM.
(C) Expression of CX3CR1 on iMGLs corresponds to tdTomato expression, as demonstrated by FACS. H9 CX3CR1-tdTomato iMGLs express
CD11b, CD45, and TREM2, but not CCR2 as determined by FACS.
(D) iMGLs, but not H9 CX3CR1-tdTomato ESCs or H9 CX3CR1-tdTomato HPCs, express P2RY12, TREM2, as well as tdTomato. Scale bars,
50 mm.
(legend continued on next page)
Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020 1023
Functional Testing of H9 CX3CR1-tdTomato-Derived
iMGLs
For our reporter line to be a useful tool formicroglia, neuro-
science, and drug discovery researchers, it must perform
robustly in a variety of experimental setups, including im-
aging, co-culture and functional assays, as well as for a va-
riety of readouts, including those that require either cells or
media for analysis. Thus, we sought to validate our line in
these settings. Cytokine responses and phagocytosis of
cells expressing damage or danger signals, as well as inter-
actions with synapses, are critical in vivo microglial func-
tions. We confirmed that H9 CX3CR1-tdTomato secrete
the appropriate range of cytokines and chemokines in
response to LPS (Figure 3A) and phagocytose fluorescently
labeled synaptosomes isolated from human brain (Figures
3B and S3A). We also showed that H9 CX3CR1-tdTomato
iMGLs can internalize native synaptic material immuno-
stained with PSD95 when co-cultured with human ReN
cell cultures containing neurons and glia (Figure 3C).
Together these data show that CX3CR1-tdTomato-derived
iMGLs possess the functional properties of microglia
in vitro.
Co-culture of iMGLs with Human Neurons and Glia
Shifts Transcriptional State toward Ex VivoMicroglial
Identity
It is becoming clear that the brain niche specifies an inde-
pendent component of microglial cell fate (Gosselin
et al., 2014). To attempt to mimic context-specific func-
tions and cell identity of microglia, to date iMGLs have
been co-cultured with rat hippocampal neurons (Abud
et al., 2017), hiPSC-derived neurons (Takata et al., 2017),
NPC-conditionedmedium (Muffat et al., 2016), cerebral or-
ganoids (Abud et al., 2017; Brownjohn et al., 2018; Ormel
et al., 2018), or astrocytes (Pandya et al., 2017), each re-
ported to partially improve functions and morphology of
iMGLs. To further characterize this, we included transcrip-
tional data from iMGLs co-cultured with rat hippocampal
neurons (iMGL_rat_neuron; Abud et al., 2017), or NPC-
conditioned medium (iMGL_muffat + NCM; Muffat et al.,
2016). Curiously, this did not significantly enhance the
similarity of iMGLs to ex vivo microglia (Figures 4A and
4B), suggesting that signals provided by direct contact
with rat hippocampal neurons or NPC-conditioned
medium are not sufficient to significantly shift the tran-
scriptional signature of iMGLs toward ex vivo microglia
(Figures 4A and 4B). This may be attributed either to the
species differences between rodent and human microglia(E and F) River plot showing the kinetics of cell identity transitions du
measured by expression of the markers TRA-1-60, CD43, CD11b, CD45, C
as gated on the markers shown. Ungated FACS plots of the live cell p
See also Figures S1 and S2.
1024 Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020(Galatro et al., 2017; Gosselin et al., 2017; Smith and Dra-
gunow, 2014), or to the absence of astrocyte-derived signals
requisite for microglial maturation (Bohlen et al., 2017).
Similarly, our data show that an additional astrocyte-
derived metabolite required by microglia (cholesterol)
was unable to push the iMGL molecular identity toward
ex vivomicroglia (Figures 4A and 4B).We thus hypothesized
that co-culture of iMGLs or their precursors with human
glia and neurons may recapitulate the components of the
microglial transcriptional network that are controlled
through cell-cell contacts. For this, we utilized ReN VM
cells, which are immortalized human NPCs, shown to be
electrophysiologically active upon differentiation to a
neuron-glia culture (Choi et al., 2014). Indeed, the resul-
tant transcriptomes of FACS-sorted iMGLs co-cultured
with ReN-derived neurons and glia (Figures S3B and S3C)
were shifted in both the first and secondMDS components
toward ex vivo microglia, suggesting acquisition of aspects
of the ex vivo transcriptional signature (Figures 4A, 4B,
and S4A). Similarly, when we integrated transcriptional
data from a recent publication showing innate develop-
ment of microglia in cerebral organoids (Ormel et al.,
2018), the iMGL signatures were also shifted in the second
MDS component toward an ex-vivo-like state, further high-
lighting the capacity of direct contact with niche cells to in-
fluence microglial molecular identity. Our data thus show
two independent components required by microglia to
establish an ex vivo identity—the first MDS component de-
fines the developmental trajectory of microglia from iPSCs
through iHPCs to iMGLs and thus likely represents matu-
rity of microglia. The second component represents signals
provided by the niche, as it separates in vitro and ex vivomi-
croglia. Interestingly, organoid derived microglia (oMGL),
both at 38 and 52 days of culture, were not as far shifted
along the first MDS component trajectory between iHPCs
and iMGL/microglia, suggestive of incomplete maturation
toward the microglial lineage. These results are consistent
with the role of the developmental trajectory with initial
epigenetic priming outside the brain (or brain-like environ-
ment) in establishing microglial lineage identity, followed
by niche signals for tissue imprinting (Amit et al., 2016).
To investigate the nature of the molecular transition
induced in iMGLs by contact with human glia and neurons
further, we focused on changes to transcription factors (TFs)
shown to be deregulated in microglia in vitro. TF landscapes
govern cell identity transitions and are master regulators of
signals transduced fromtheenvironment; this isparticularly
evident in theadaptationsofmacrophage subpopulations toring differentiation of iPSCs to iHPCs (E) and iHPCs to iMGLs (F), as
X3CR1-tdTomato, and TREM2. Population proportions are presented
opulations are in Figures S2A and S2B.
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Figure 3. H9.CX3CR1-tdTomato iMGLs Secrete Cytokines, Internalize Native Synaptic Material, and Can Be Readily Tracked in
Co-cultures
(A) Cytometric bead array for the cytokines and chemokines shown in H9.CX3CR1-tdTomato iMGLs basally (open circles), or stimulated for
24 h with LPS (closed circles, 100 ng/mL). Points represent the average of three individual wells from independent differentiations and are
expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by student’s t test.
(B) Histograms showing the percentage of live tdTomato+ iMGLs phagocytosing one, two, or more synaptosome-conjugated fluores-
cent blue carboxylate 2.0-mm microspheres after 1.5 h co-incubation, as determined by FACS. Cells were pre-treated for 22.5 h with LPS
(100 ng/mL). Histograms are representative of three independent experiments performed in triplicate wells.
(C) iMGLs at D21 were co-cultured for 21 days with ReN cell-derived mixture of human glia and neurons, stained with MAP2 and GFAP
(i), MAP2 and IBA1 (ii), and synapsin and PSD95 (iii), and visualized using confocal microscopy. Individual channel images
(legend continued on next page)
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their environment (Bennett et al., 2018; Gosselin et al.,
2014).We thus reasoned that earlyorpartial cell fate changes
could be captured by examining whether TF networks de-
regulated upon in vitro culturemay be restored by co-culture
with human neurons and glia. We examined whether
expression levels of the 63 TFs associated with ex-vivo-spe-
cific super enhancers (ATAC-seq open chromatin regions
also carrying an H3K27ac mark) or ex-vivo-enriched motifs
(Gosselin et al., 2017) were restored to ex vivo levels. We first
performed a clustering and correlation analysis of all iMGL
transcriptomes based on expression levels of these 63 critical
microglial TFs. This analysis showed that iMGLs cultured us-
ing the Abud protocol that were co-cultured with neurons/
glia clustered with bona fide microglia, and that the expres-
sion of microglial TFs was highly correlated between these
samples (Figures 4C and S4B). Similarly, the transcriptomes
from oMGL that innately develop within organoids (Ormel
et al., 2018) also clustered together with ex vivomicroglia in
this analysis. Importantly, althoughmicroglial TFs were un-
changed in iMGLs cultured in cholesterol (Figure4D), 12mi-
croglial TFs were significantly upregulated in iMGL_abud +
ReN, including multiple TFs from the JUN, FOS, EGR, and
KLF families (Figure 4E). Together, these data show that
direct interactions of iMGLs with human neurons and glia
leads to a shift in the transcriptional program of iMGLs to-
ward a more ex-vivo-like state.
Nonetheless, important differences exist between iMGLs
and ex vivo microglia, even in the presence of human neu-
rons and glia—indeed 1,967 differentially expressed genes
(DEGs) remain, although this is a significant improvement
on the 4,461 DEGs between ex vivo microglia and iMGL_a-
bud (adj. p < 0.05; Table S1). As ReN cells are derived from
fetal ventral mesencephalon, it is possible that co-culture
with adult neurons and astrocytes or glia may provide addi-
tional maturation signals. Moreover, microglial transcrip-
tomes are regionally heterogeneous, at least within the
mouse (Grabert et al., 2016), which may be an epigeneti-
cally controlled function of microenvironment and
neuronal turnover rates (Ayata et al., 2018); thus, co-culture
with cells from a particular region of interest may also yield
increased molecular resemblance to bona fide microglia.
Together, our data provide a framework as well as laboratory
and transcriptional tools. These tools allow the comparison
and integration of existing and newly generated datasets,
and a pluripotent microglia reporter line that can be used
to track iMGLs and their media, alone or in co-culture sys-
tems, for a variety of molecular and functional assays or
drug screening approaches.are shown as well as the merged images. Arrows represent co-lo
50 mm.
See also Figure S3.
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Resource Availability
Materials Availability
The H9.CX3CR1-tdTomato cell line is registered in hPSCReg as
WAe009-A-24 (synonym MIPSe010-A-24).
Data and Code Availability
All sequencing data have been deposited to GEO under accession
number GEO: GSE125872. The accession number for the raw
data reported in this paper is GEO: GSE125872.Differentiation of iPSCs/ESCs to Microglia-like Cells
Eight iPSC lines, as described previously (Oksanen et al., 2017),
were used for validation of the protocol and the data are presented
in Figures 1 and S1. The generation of H9 CX3CR1-tdTomato ESCs
is described later in the Gene Editing section and was approved by
the Monash University Human Research Ethics Committee (Proj-
ect Number: 8826) and the Monash University Institutional
Biosafety Committee (Reference: 23066).
The protocol for iMGL derivation was adapted from Abud et al.
with modifications from the StemDiff Hematopoietic Kit (05310,
STEMCELL Technologies) similar to (McQuade et al., 2018). H9
CX3CR1-tdTomato cells were cultured on vitronectin (A14700,
Thermo Fisher Scientific)-coated T25 flasks in E8 medium
(A1517001, Thermo Fisher Scientific). Two days before differentia-
tion, cells were detached in 0.5 mM EDTA and 40–80 colonies/well
were seeded in a 12-well plate coated with Matrigel (1:40, 354277,
hESC-qualified matrix, LDEV-free, Falcon) in E8 medium. On day
0 (D0), E8 was exchanged for 1 mL of supplemented iHPC differen-
tiation base medium (Supplemental Experimental Procedures).
iHPC differentiation base medium supplemented with fibroblast
growth factor 2 (FGF2) (50 ng/mL, 130-093-564, Miltenyi Biotec),
BMP4 (50 ng/mL, 130-111-165, Miltenyi Biotec), Activin A
(12.5 ng/mL, 130-115-010, Miltenyi Biotec), ROCKi (1 mM, 130-
103-922,Miltenyi Biotec), and LiCl (2mM,L7026, Sigma), and incu-
bated in a hypoxic incubator (5% oxygen). On D2, medium was
changedto1mLof iHPCdifferentiationbasemediumsupplemented
withFGF2(50ng/mL)andvascular endothelialgrowthfactor (VEGF)
(50 ng/mL, 130-109-385) and incubated in a hypoxic incubator. On
D4,mediumwaschangedto1mLiHPCdifferentiationbasemedium
containing human FGF2 (50 ng/mL), VEGF (50 ng/mL), thrombo-
poietin (TPO) (50 ng/mL, 130-095-752, Miltenyi Biotec), stem cell
factor (10 ng/mL, 130-096-695, Miltenyi Biotec), IL-6 (50 ng/mL,
PHC0061, Thermo Fisher Scientific), and IL-3 (10 ng/mL,
PHC0031, ThermoFisher Scientific) and incubatedundernormoxia.
Half themediumwas replaced onD5 and D7 as on D4. OnD10, the
supernatant containing theHPCswas collected, centrifuged (3003 g
for5minat roomtemperature [RT]), then0.5mLcell-containingme-
dium was replaced and supplemented with 0.5 mL fresh medium.
We note that hypoxia, TPO, and IL-6 are not required for 2D primi-
tive myelopoiesis as assessed by the percentage of CD43+ cells atcalization between tdTomato, synapsin and PSD95. Scale bars,
AC D
E
B
Figure 4. Co-culture with ReN Human Glia/Neurons, but Not Cholesterol alone, Shifts iMGL Transcriptional Profile toward an
Ex Vivo Cell State
(A and B) Multidimensional scaling analysis of the integrated datasets as in Figures 1A and 1B presented as MDS dimension 1 versus 2 (A)
and 2 versus 3 (B), including the RNA-seq datasets generated in this study. iMGL_abud group includes the original data from Abud et al.
(2017) and data from this study, generated using the same protocol. As in Figures 1A and 1B, ex vivomicroglia (exMGL) and iMGL_abud are
included for comparison. Datasets include iMGLs co-cultured with rat hippocampal neurons, cholesterol, or ReN cells (iMGL_rat_neuron,
(legend continued on next page)
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D12.OnD12, supernatantcontainingHPCswascollectedandplated
onto Matrigel-coated 12-well plates at 1 3 105 cells/well in iMGL
complete differentiation medium (Supplemental Experimental Pro-
cedures). The yield of iMGLs varies from 1:80 to 1:200 (i.e., 13 103
ESCsyields 83104 to23105HPCs). Every2days, eachwellwas sup-
plemented with 0.5mL of complete differentiationmedium, and at
D22 cells were replated and a 50% media change was performed
every 2 days. From D35-38, iMGLs were cultured in complete
iMGL differentiation medium supplemented with human CD200
(100 ng/mL, C311, Novoprotein) and CX3CL1 (100 ng/mL, 300-
31, PeproTech). iMGLs were stimulated with LPS for 24 h before
RNA isolation or collection of culture supernatant.Gene Editing
For gene targeting, H9 wild-type hESCs were co-cultured on 6-cm2
dishes with mouse embryonic fibroblasts (MEFs) until 80%
confluent in hESC media (20% v/v KnockOut Serum Replacement,
1% non-essential amino acids, 0.5% GlutaMAX I, 1% v/v P/S,
0.625% v/v b-mercaptoethanol in DMEM/F12 + GlutaMAX I (all
Thermo Fisher Scientific), replaced daily. For targeting, confluent
cells were dissociated in 1 mL Accutase, collected into a 15-mL Fal-
con, centrifuged (1603 g, 4 min, RT), and depleted of MEFs for 1 h
in an uncoated 6-cm2 dish with hESC media. Nucleofection was
achieved by following themanufacturer’s instructions for the Lonza
Amaxa Primary P3 Kit (V4XP-3024, Lonza). On the day of targeting,
12,000/cm2 MEFs were dissociated as described above and one
million cells/1 mg vector DNA/1 mg small guide RNA were resus-
pended in 100 mL of Lonza Amaxa Primary P3 nucleofection solu-
tion. Nucleofection was performed using the Lonza Nucleofection
cuvette and the CB-156 setting. Cells were immediately replated
(12,000/cm2) onto a 6-cm2 dish in hESC media supplemented
with 10 mM ROCKi, and 20 ng/mL FGF2. Seventy two hours after
nucleofection, cells were incubated in hESC medium containing
G418 at 50 ng/mL (Thermo Fisher Scientific). Medium containing
G418was replaced daily for 10 days. Surviving colonies weremanu-
ally picked using a dissecting microscope, and seeded into individ-
ual wells of a 12-well plate (12,000/cm2). Clones were grown to con-
fluency, expanded into 6-well plates, and pellets frozen at20C for
gDNA extraction and PCR screening, or cells frozen in Freeze Mix
(10%v/vDMSO, 50%v/v fetal bovine serum, 40%v/v hESCmedia).Cytometric Bead Array
CBAwas carried out using the BD CBA human flexi kit using a pro-
tocol modified from that of the manufacturer. Five microliters ofAbud et al., 2017; iMGL_abud + cholesterol, this study; iMGL_abud +
Muffat et al., 2016), organoid microglia at D38 or 52 (oMGL38_orme
(C) Cluster dendrogram (ward.D2) and correlation analysis (Pearson
protocols.
(D) Bar plot showing gene expression changes in ex vivo super enhanc
and iMGL_abud protocols (logFC>0 represents upregulation in iMGL_
rection of change for gene expression in iMG_abud + cholesterol is t
microglia (salmon).
(E) Bar plot as for (D), depicting TF gene expression changes between
p < 0.001, ***adj. p < 0.0001.
See also Figure S3 and S4.
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diluent) and samples were incubated with 5 mL of Capture Bead
mix (containing 0.1 mL of each cytokine Capture Bead diluted in
Capture Bead Diluent) for 1 h in a 96-well V-bottom assay plate.
Wells were incubated with 5 mL PE detection reagentmix (contain-
ing 0.1 mL of each cytokine PE reagent) diluted in Detection
Reagent Diluent for 1 h in the dark. Wells were then washed
once with 200 mL of wash buffer, and beads resuspended in 80 mL
of wash buffer for analysis by FACS using the LSRFortessa X-20
(BD Biosciences). At least 200 single bead events from each
cytokine population were collected. Results obtained were
analyzed using the FCAPArray software v.3.0 (BD). Differences be-
tween LPS-stimulated and non-stimulated groups for secretion of
individual cytokines were calculated using two-tailed student’s t
test.Phagocytosis Assay
Phagocytosis assays were performed using pHrodo-red or pHrodo-
green E. coli bio-particles (P35361 or P35366, Thermo Fisher Scien-
tific) as per the manufacturer’s instructions. In brief, particles were
resuspended in 2 mL of iMGL differentiation medium, sonicated
for 50 s, then vortexed for at least 30 s. Microglia were grown on
12-well plates at 13 105 cells per well in complete iMGLmedium.
Twenty four hours before phagocytosis assay, half the wells were
treated with LPS (100 ng/mL, L4391, Sigma). One hour before
assay, half of the LPS and non-LPS wells were treated with cytocha-
lasin D (C8273, Sigma) at 10 mM to inhibit phagocytosis, and incu-
bated for 1 h at 37C. Immediately before the phagocytosis assay,
particles were vortexed for at least 30 s, and diluted at a 1:60 con-
centration. Particles were added to wells, and incubated for 1 h at
37C in the dark. Following incubation with bio-particles, iMGLs
were collected in a 15-mL tube, washed in PBS 23, and centrifuged
at 300 3 g for 5 min between washes. Microglia were resuspended
in 100 mL of FACS buffer (PBS with 0.1% w/v BSA, 2.5 mM EDTA)
before FACS analysis.Synaptosome Isolation, Labeling, and Phagocytosis
Synaptosomes were isolated from human brain tissue (obtained
from Victorian Brain Bank, Ethics Approval: Monash University
MUHREC, 2016-0554) according to the Syn-PER Synaptic Protein
Extraction Reagent (87793, Thermo Fisher Scientific) protocol.
Protein concentrations were measured by nanodrop, and synapto-
somes labeled with blue fluorescent 2.0-mm FluoSpheres (carbox-
ylate-modified microspheres; F8824, Life Technologies) accordingReN, this study), or NPC conditioned medium (iMGL_muffat + NCM;
l and oMGL52_ormel; Ormel et al., 2018).
) of TF expression in ex vivo microglia and various in vitro iMGL
er or motif TFs with abs(logFC)>1 between iMGL_abud + cholesterol
abud + cholesterol). The color of the bars depicts whether the di-
he same as that for ex vivo microglia (teal) or opposite to ex vivo
iMGL_abud + ReN and iMGL_abud protocols. *adj. p < 0.05, **adj.
to the manufacturer’s instructions. In brief, 5.5 mg synaptosomes
was resuspended at 5 mg/mL in MES buffer (1.1 mL) for 15 min at
RTand labeled by addition of 7.6 mg EDAC (E2247, Thermo Fisher
Scientific) for 2 h at RT, then overnight (O/N) at 4C. Conjugates
were sonicated for 2 3 10 cycles (20 s on, 30 s off), then 16.2 mg
glycine was added. After washing, conjugates were resuspended
in 1 mL 1% (w/v) BSA with 2 mM sodium azide, and stored at
4C before addition to cells. After 22.5 h LPS treatment, iMGLs
were incubated with conjugated synaptosomes (3.44 mg/mL) for
a further 1.5 h. iMGLs were collected as above and analyzed by
FACS for internalization of synaptosome labeled particles.
Nanoluciferase Assay
Nanoluciferase activity in iMGL supernatants was assessed using
the Nano-Glo Luciferase Assay System (N1110, Promega) accord-
ing to the manufacturer’s instructions. In brief, Nanoluciferase
Assay Reagent was prepared immediately before the assay with
Nano-Glo Luciferase Assay Substrate diluted 1:50 in Nano-Glo
Luciferase Assay Buffer. Assay reagent (50 mL) was mixed with
50 mL cell-conditioned culture medium for 3 min and nanolucifer-
ase activity was measured using the luminescence detection mode
on a FLUOstar Omega microplate reader (BMG Labtech). The
average signal per well over 10 min, beginning 3 min after
substrate addition, was used as the final reading.
Culture and Differentiation of ReN Neural Progenitor
Cells
ReN cells (SCC008, Millipore) were maintained and differentiated
as described previously (Choi et al., 2014). In brief, cells weremain-
tained on Matrigel-coated flasks (BD Biosciences) in DMEM/F12
(11320033, Thermo Fisher Scientific) supplemented with 2 mg/
mL heparin (07980, STEMCELL Technologies), 2% (v/v) B27,
20 mg/mL EGF (130-097-749, Miltenyi Biotec), 20 mg/mL basic
FGF (130-093-843, Miltenyi Biotec), and 1% (v/v) P/S. Neuronal
and glial differentiation was achieved by growth factor with-
drawal, with twice-weekly half media changes. We note that ReN
cells do not differentiate to convincing GLAST+/S100+ astrocytes,
although they do stain for GFAP. For co-culture assays, iMGLs
were added to D21-differentiated ReN cells for a further 21 days
at a ratio of (1:10), either in 6- or 48-well plate on coverslips, for
FACS and immunofluorescence, respectively.
Flow Cytometry and Cell Sorting
Cells were stained with antibodies to microglial and macrophage
cell surface markers (CX3CR1-BV786, 1:20, 744489, BD Biosci-
ences; CD11b-BV650, 1:100, 101259, BioLegend; CCR2-BV421,
1:20, 564067, BD Biosciences; TREM2-APC, 1:10, FAB17291A
R&D Systems or human TREM2 antibody 1:15, AF1828, R&D;
and donkey anti-goat Alexa Fluor 647 1:2,000, A-21447, Thermo
Fisher Scientific; CD45-APC.Cy7, 1:200, 25-0459-T100, Tonbo Bio-
sciences; CD43-APC, 1:200, 343206, BioLegend, TRA-1-60
BUV395, 1:100, 563878, BD Biosciences; CD235a, PE-cy7, 1:200,
349112, BioLegend). Zombie violet (1:200) or propidium iodide
(1:500) were used to discriminate live/dead cells, as appropriate
for the antibody panel. For co-culture RNA-seq experiments, the
CX3CR1-tdTomato reporter was used for isolation of iMGLs from
glia-neuron co-cultures using the FACSAria III cell sorter.Immunofluorescence
iMGLs were grown alone or in co-culture with ReN cells, on 8-mm
glass coverslips (72296-08 PD25, Emgrid Australia) coated with Ma-
trigel. Cells were fixed with 4% (v/v) paraformaldehyde (PFA) for
1 min, added directly to medium. Medium and PFA were replaced
with pre-warmed 4% (v/v) PFA for 10 min at RT. After three PBS
washes, cells were blocked for 1 h with 10% (v/v) donkey serum
or normal goat serum, then stained with the primary antibodies
O/N at 4C: P2RY12 (1:400, HPA013796, Sigma), TREM2 (1:200,
AF1828-SP, R&D), IBA1 (1:500, 019–19741, Novachem), MAP2
(1:500, MAB3418, Millipore), GFAP (1:500, Z0334, Dako), Synapsin
I (1:1,500, 574777,Millipore), PSD95 (1:500, ab12093Abcam).After
33withPBSTwashes, cells were incubated rocking for 2 h at RTwith
either Alexa Fluor 488 donkey anti-goat (1:800, A-11055, Thermo
Fisher Scientific), Alexa Fluor 488 goat anti-rabbit (1:800, A-
11008, Thermo Fisher Scientific), Alexa Fluor 488 goat anti-mouse
(1:800, A-11001, Thermo Fisher Scientific), or Alexa Fluor 647
donkey anti-rabbit (1:800, A31573, Thermo Fisher Scientific), Alexa
Fluor 647 donkey anti-goat (1:800, A21447, Thermo Fisher Scienti-
fic), followed by DAPI (1 mg/mL, D1306, Thermo Fisher Scientific).
Coverslips were washed 23 with PBST, then mounted with Dako
Fluorescence Mounting Medium (S3023, Dako). Slides from ReN-
iMGL co-cultures were imaged on a Nikon C1 confocal microscope
using a 403 oil 1.4 NA objective and 13 zoom with 1,024 3 1,024
resolution, resulting in a pixel size of 90 nm. Slides for iMGLmono-
cultures were imaged on a Leica SP8 confocal microscope using a
403 oil 1.24 NA objective and 0.753 zoomwith 2,0483 2,048 res-
olution, resulting in a pixel size of 188 nm.RNA-Seq
RNA-Seq Library Construction and Sequencing
RNA extraction from1 to 103 104 FACS-sortedCX3CR1+ iMGLs or
from two wells of iMGLs harvested directly from 12-well plates,
was performed on QIAcube (QIAGEN) using an RNeasy Micro Kit
(74004, QIAGEN). RNA quality was assessed on the Bioanalyser
(Agilent RNA 6000 Pico Kit). Libraries were prepared with 0.5–
2 ng RNA, RNA integrity numberR 8. An 8-bp sample index (list
below) and a 10-bp unique molecular identifier (UMI) were added
during initial poly(A) priming and pooled samples were amplified
using a template switching oligonucleotide. The Illumina P5 (50
AAT GAT ACG GCG ACC GA 3’) and P7 (50 CAA GCA GAA GAC
GGC ATA CGA GAT 3’) sequences were added by PCR and Nextera
transposase, respectively. The library was designed so that the for-
ward read (R1) uses a custom primer (50 GCC TGT CCG CGG AAG
CAG TGG TAT CAA CGC AGA GTA C 3’) to sequence directly into
the index and then the 10-bp UMI. The reverse read (R2) uses the
standard R2 primer to sequence cDNA in the sense direction for
transcript identification. Sequencingwas on the NextSeq 550 (Illu-
mina), using the V2 High-Output Kit (Illumina) and the Illumina
Protocol 15046563 v.02, generating two reads per cluster
composed of a 19-bp R1 and a 72-bp R2.
An 8-bp sample index sequences used for sample multiplexing
for RNA-seq:
TAAGGCGA; CGTACTAG; AGGCAGAA; TCCTGAGC; GGACT
CCT; TAGGCATG; CTCTCTAC; CGAGGCTG; AAGAGGCA; GTA
GAGGA; GCTCATGA; ATCTCAGG; ACTCGCTA; GGAGCTAC;
GCGTAGTA; CGGAGCCT; TACGCTGC; ATGCGCAG; TAGCGStem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020 1029
CTC; ACTGAGCG; CCTAAGAC; CGATCAGT; TGCAGCTA; TCGA
CGTC.
Demultiplexing and Mapping
Sequencing reads were processed using in-house pipelines con-
sisting of sabre tools (https://github.com/serine/sabre) and
RNAsik (Tsyganov et al., 2018). Samples were demultiplexed
with a fork of sabre tools with the commands below. Raw data
were processed with an RNAsik pipeline to generate QC metrics,
including percentage of reads mapped and assigned to the refer-
ence genome and duplication rates, and raw read counts for dif-
ferential expression analysis. Demultiplexed UMI-tagged
sequencing reads were aligned to the human genome (Ensembl
GRCh38 primary assembly) using RNAsik. Read deduplication
based on UMIs was performed with Je markdupes in RNAsik
and transcript read counts calculated with featureCounts (Liao
et al., 2014).
sabre pe -f ${RAW_DATA}/MultiplexRNASeq_S1_R1_001.
fastq.gzy
-r ${RAW_DATA}/MultiplexRNASeq_S1_R2_001.fastq.gzy
-b ${BARCODE}y
–combiney
–umiy
–max-mismatch 1y
–min-umi-len 9y
–max-5prime-crop 2y
–stats demultiplex.statsy
–no-comment
‘combine‘—merges R1 and R2 since R1 only holds "metadata,"
i.e., sample identity
‘umi‘—append umi into FASTQ header
‘min-umi-len‘—trim longer umis to 9 bases, discard umi (reads)
that are shorter than 9
‘max-5prime-crop‘—if matching barcode cannot be found at 5ʹ
of R1, remove 1 base, with maximum bases allowed to be removed
set to 2
Normalization and Integration of Existing Microglia
RNA-Seq Datasets
To compare different microglia-like cells and effect of in vitro cul-
ture we integrated the publicly available datasets (below). -Set Number Authors
GEO
Accession
No. of Samples (Used
for This Comparison)
1 Muffat et al. GEO: GSE85839 16
2 Douvaras et al. GEO: GSE97744. 24 (22)
3 Abud et al. GEO: GSE89189. 43 (40)
4 Gosselin et al. GEO: GSE89960 64
5 Galatro et al. GEO: GSE99074 65
6 Ormel et al. GEO: GSE102335 16 (13)
7 Grubman et al. GEO: GSE125872 16 (14)
Combined 244 (234)
1030 Stem Cell Reports j Vol. 14 j 1018–1032 j June 9, 2020Processed RNA-seq data were used where possible. Datasets 1–3
are available as fragments per kilobase of transcript per million
mapped reads (FPKM) tables; datasets 4, 5, and 6 as counts. Read
counts tables were transformed to FPKMwith the edgeR (Robinson
et al., 2010) (v.3.22.3) rpkm function and using average transcript
length as gene length. Data were normalizedwith the removeBatch-
Effect function specifying the dataset numbers as batch and com-
mon groups where possible. The shared groups include brain sam-
ples, ex vivo monocytes, ex vivo microglia, and iPSCs. Normalized
data were log transformed and used as input for plotMDS to
generate theMDS analysis. For the heatmaps to visualize clustering
of samples and genes, normalized data were used as described
above. Samples pertaining to the ex vivo and in vitromicroglia cells
were selected (a total of 98 samples). The genes of interest (63 TFs
from Gosselin et al., 2017) are selected from the expression data.
Genes that were not widely expressed with an RPKM value of
>0.5 in more than 10 samples, including ex vivo microglia, were
filtered out. For Figure 4C, Pearson correlation was computed for
all samples and visualized with heatmap.2 (using "ward.D2" clus-
tering method) from the gplots package (v.3.0.1). For Figure S4B
the RPKMvalues are shown and heatmap.2was used to cluster sam-
ples using ward.D2.
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